Skip to main content

Table 5 Bivariate analysis of enterococci infections at the UoGTH, February 28, 2014 to May 1, 2014

From: Isolation of enterococci, their antimicrobial susceptibility patterns and associated factors among patients attending at the University of Gondar Teaching Hospital

Characteristics

Total

No. (%)

Enterococci infection

COR (95% CI)

P- value

Presence

No. (%)

Absence

No. (%)

Total

385 (100%)

24 (6.2%)

361 (93.8%)

  

Sex

 Female

176

10 (5.7)

166 (94.3)

1.19 (0.51–2.75)

0.68

 Male

209

14 (6.7)

195 (93.3)

1.00

 

Age

    

0.06

 <5

123

12 (9.8)

111 (90.2)

0.26 (0.03–2.10)

0.21

 5–14

36

1 (2.8)

35 (97.2)

0.26 (0.07–0.96)

0.04

 15–30

108

3 (2.8)

105 (97.2)

0.35 (0.10–1.27)

0.11

 31–50

83

3 (3.6)

80 (96.4)

1.54 (0.50–4.72)

0.45

 >50

35

5 (14.3)

30 (85.7)

1.00

 

Hospital stay (hours)

 <48

353

7 (2)

346 (98)

1.00

 

 ≥48

32

17 (53)

15 (47)

56.02 (18.32–178.39)

0.00

HIV

 Negative

367

22 (6)

345 (94)

1.00

 

 Positive

18

2 (0.1)

16 (99.9)

1.96 (0.00–9.79)

0.39

CD4 counta

 <200

6

0 (0.0)

6 (100)

0.00 (0.00–9.76)

 

 >200

12

2 (16.7)

10 (83.3)

1.00

0.52

HAARTa

 Pre

9

2 (22.2)

7 (87.8)

1.00

 

 On

9

0 (0.0)

9 (100)

0.00 (0.00–4.38)

0.47

WHO stagea

    

1.00

 I

5

2 (40)

3 (60)

1.00

 

 II

1

0 (0.0)

1 (100)

0.00 (0.00–60.98)

1.00

 III

6

0 (0.0)

6 (100)

0.00 (0.00–3.71)

0.18

 IV

6

0 (0.0)

6 (100)

0.00 (0.00–3.71)

0.18

History of:

 Animal contact

111

10 (9)

101 (90)

1.84 (0.73–4.58)

0.15

 Antibiotics usage

54

14 (25.9)

40 (74.1)

11.24 (4.34–29.47)

0.00

 Cancer

3

1 (33.3)

2 (66.7)

7.80 (0.00–116.25)

0.18

 Catheterization

17

11 (64.7)

6 (35.3)

50.06 (14.24–184.31)

0.00

 Diabetics

9

0 (0.0)

9 (100)

0.00 (0.00–9.28)

1.00

 Cotrimoxazole prophylaxisa

36

2 (5.6)

34 (94.4)

0.87 (0.20 - 3.88)

1.00

 Hospitalization

40

11 (27.5)

29 (72.5)

9.69 (3.66–25.68)

0.00

 Immunosuppressive usage

51

3 (5.9)

48 (94.1)

0.93 (0.21–3.47)

1.00

 Laboratory confirmed Bacterial infection

10

3 (30)

7 (70)

7.22 (1.36–34.43)

0.02

 Prosthetic device usage

10

1 (10)

9 (90)

1.70 (0.21–14.01)

0.48

 Surgery

6

0 (0.0)

6 (100)

0.00 (0.00–14.88)

1.00

 UTI

55

2 (3.6)

53 (96.4)

0.53 (0.08–2.42)

0.55

  1. aOnly for HIV positives